Ipsen obtained marketing approval for febuxostat from the European Medicines Agency in April 2008 , Takeda obtained FDA approval in February 2009 .
Teijin obtained approval from the Japanese authorities in 2011 .
Ipsen obtained marketing approval for febuxostat from the European Medicines Agency in April 2008 , Takeda obtained FDA approval in February 2009 , and Teijin obtained approval from the Japanese authorities in 2011 .